Porton PharmaTech, d.o.o.

SHARE

Porton Nominated for the 2025 Sedex Supply Chain Award Porton Nominated for the 2025 Sedex Supply Chain Award
20.08.2025

Porton Nominated for the 2025 Sedex Supply Chain Award

Shanghai, August 20, 2025 – Porton Pharma Solutions Ltd. (“Porton”) was honored with a nomination for the Positive Endeavors Award at the 2025 Sedex Supply Chain Award Ceremony. The recognition highlights Porton's unwavering commitment to sustainability and responsible business practices.

Porton Nominated for the 2025 Sedex Supply Chain Award

Sedex is a leading global platform for managing supply chains, with over 85,000 member companies worldwide. The Sedex Supply Chain Award, a flagship recognition in global supply chain management, honors companies, organizations and individuals for their contributions and innovations in advancing environmental and social responsibility.

Porton has established an ESG governance framework spanning the governance, management and execution levels, embedding sustainability into its strategy and operations. Business ethics, environmental protection, responsible supply chain practices and employee rights are integrated across processes and systems. Through regular reviews and evaluations, Porton continuously strengthens its governance mechanisms to ensure effective implementation and ongoing improvement. This approach aligns growth with sustainability while meeting rising client expectations for responsible business conduct.

As an integral part of the global pharmaceutical supply chain, Porton actively collaborates with clients to advance a sustainable future for the industry. In 2024, Porton joined the Sustainable Markets Initiative and launched green electricity procurement. In 2025, Porton's near-term science-based targets were validated by the Science Based Targets initiative (SBTi). That June, Porton announced environmental goals focused on energy, water and waste management, further aligning its practices with both its own sustainability strategy and client expectations.

Moving forward, Porton will continue to enhance its compliance management, promote sustainable development, and actively expand collaborative efforts across the industry chain to accelerate the development of a sustainable pharmaceutical ecosystem.

SHARE

Porton Nominated for the 2025 Sedex Supply Chain Award Porton Nominated for the 2025 Sedex Supply Chain Award
Porton Nominated for the 2025 Sedex Supply Chain Award Porton to Showcase Integrated CDMO Expertise at CPHI Frankfurt 2025 Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology Porton and Repare Therapeutics Collaborate on OPRD Publication, Demonstrating Strength in Synthetic Process Development and Optimization Porton Announces 2030 Sustainability Targets on World Environment Day Porton Awarded Gold Medal by EcoVadis, Ranked Among the Top 5% Globally Porton Pharma Solutions Celebrates 20 Years of Excellence and Innovation Porton to Showcase Integrated CDMO Expertise at BOS Basel 2025 Join Us at Chemspec Europe 2025 in June Porton's Near-Term Target Validated by the SBTi Porton Wins Outsourced Pharma 2025 CDMO Leadership Award Porton to Showcase Cutting-edge Innovations at BIO-Europe Spring 2025 Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials. Porton’s New Modality Capacity Upgrade Ceremony Successfully Held Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review Technical Enability | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference Keep hope alive! We invite you to stay tuned to DMD Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details